Wow! For the first time in history, the research of mesenchymal stem cells surpassed hematopoietic stem cell research within the scientific literature in 2015.
This is major news for the stem cell community, because it represents a shift in stem cell research activity.
Mesenchymal stem cells, of the five types analyzed, were the only type to also experience an increase in frequency of publication from 2014 to 2015 as well. Conversely, all four other types experienced decreases in publication during the aforementioned period.
Check out the metrics here: Mesenchymal Stem Cells Surpass Hematopoietic Stem Cells in the Scientific Literature for the 1st Time in History
BioInformant also just released a compelling and highly informative interview with Dr. Chris Centeno, an international expert in the use of mesenchymal stem cells (MSCs) for orthopedic applications. Read the two-part interview here to learn how MSCs are forever changing the landscape of orthopedic applications:
If you are ready to invest in a deeper understanding of stem cell markets, please view “Mesenchymal Stem Cells – Advances & Applications.” This report covers market size, segments, trends, and projections through 2020, as well as key metrics for the regenerative medicine (RM) and cell therapy (CT) markets.
To understand how mesenchymal stem cells fit within the research products marketplace, please view “Stem Cell Research Products – Opportunities, Tools, and Technologies.” This global strategic report is one of the most thorough we have ever released, because, like our “Advances and Applications” report mentioned above, it contains market size, segments, trends, and projections through 2020, as well a social analytics and an end-user survey of nearly 300 stem cell scientists.
Remember, BioInformant is the “1st and Only Market Research Firm Specializing in the Stem Cell Market.” Get breaking stem cell news and exclusive interviews by subscribing below or follow us on Twitter or LinkedIn.